Reference Medicine provides high-quality oncology specimens sourced from IRB/EC-accredited institutions, ensuring rigorous quality control and next-day shipping. The company addresses the challenge of obtaining reliable and affordable samples for diagnostic companies and researchers, enabling them to focus on advancing cancer research and treatment.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Oncology researchers and diagnostic companies face challenges in obtaining high-quality, well-characterized biospecimens, which are critical for advancing cancer research and developing effective treatments. Variability in sample quality, inconsistent sourcing practices, and lack of comprehensive clinical data can hinder research outcomes and delay therapeutic breakthroughs.
Solution
Reference Medicine provides oncology biospecimens sourced from a global network of IRB/EC-accredited institutions, ensuring ethical compliance and rigorous quality control. The company offers a range of products, including matched sets of tissue, blood, and other biological materials, accompanied by transparent pricing and detailed clinical annotations. By acting as an extension of their customer's team, Reference Medicine streamlines the procurement process, offering next-day shipping and a "delight guarantee" to address any issues and keep experiments moving forward. Their specimens undergo quality control testing to ensure reliability and suitability for various research applications, including NGS sample preparation and biomarker characterization.
Target Audience
Reference Medicine primarily serves oncology researchers in academic institutions, pharmaceutical companies, and diagnostic firms who require high-quality, ethically sourced biospecimens for their research and development activities.
Features
- Sourcing from IRB/EC-accredited institutions worldwide, ensuring ethical compliance
- Quality control testing on all specimens to ensure reliability and suitability for research
- Transparent pricing with all fees included upfront, eliminating unexpected costs
- Next-day shipping to minimize delays in research workflows
- Matched sets of tissue, blood, and other biological materials available
- Specimens characterized for biomarker expression and other relevant clinical data
- "Delight guarantee" ensuring customer satisfaction and prompt resolution of any issues